Cyclin D1, p16 and retinoblastoma gene product expression as a predictor for prognosis in non-small cell lung cancer at stages I and II

This publication has 26 references indexed in Scilit:

• Bone-marrow microinvolvement in non-small cell lung cancer is not a reliable indicator of tumour recurrence and prognosis
  European Journal of Surgical Oncology, 2000
• The Expression of Cyclins D1 and E in Predicting Short-Term Survival in Squamous Cell Carcinoma of the Lung
  Laboratory Investigation, 2000
• c‐mos immunoreactivity is an indicator of good prognosis in lung cancer
  Histopathology, 2000
• Prognostic Implications Of Calbindin-D28k Expression in Lung Cancer: Analysis of 452 Cases
  Laboratory Investigation, 2000
• Prognostic value of the quantified expression of p185c-erbb2 in non–small cell lung cancer
  The Journal of Thoracic and Cardiovascular Surgery, 2000
• Prognostic Values of Stromal Proportion and PCNA, Ki-67, and p53 Proteins in Patients with Resected Adenocarcinoma of the Lung
  Laboratory Investigation, 2000
• G1 phase progression: Cycling on cue
  Cell, 1994
• A Cell Cycle Regulator Potentially Involved in Genesis of Many Tumor Types
  Science, 1994
• A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4
  Nature, 1993
• Mammalian G1 cyclins
  Cell, 1993